ESR1 and breast cancer: ERα positive CTCs were identified by ISET, however the number of CTCs identified by this methodology was markedly lower than by CellSearch, even in a high-CTC population indicating that this assay would be inappropriate for the low numbers of CTCs found in early breast cancer sample analysis (Table 4).